What Is the Latest Mounjaro Lawsuit Update?
As of November 2024, over 1,090 lawsuits are pending in the federal multidistrict litigation (MDL) concerning Mounjaro and similar GLP-1 receptor agonist drugs. This litigation is in its early stages, with no settlements or jury trials scheduled yet.
These lawsuits allege that Eli Lilly and the company failed to adequately warn consumers about serious gastrointestinal side effects, including gastroparesis (stomach paralysis). Additionally, the plaintiffs argue that Eli Lilly was aware of these potential risks but did not disclose them appropriately.
Has Mounjaro left you with unexpected, severe gastrointestinal pain? At Uptown Injury Law, PLLC, we understand the distress caused by gastroparesis and other serious side effects that were not fully disclosed. We don’t just file your lawsuit—we fight for your right to a normal life again.
Call us at 917-540-8728 for a free personal consultation.
Mounjaro Lawsuit Update – 2024
The Mounjaro lawsuit is making headlines, with new FDA warnings, research findings, and a rise in legal cases. Here are the latest updates on Mounjaro lawsuits:
FDA Warning on Compounded GLP-1 Drugs
In November 2024, the FDA issued a significant warning about compounded GLP-1 drugs containing tirzepatide, the active ingredient in Mounjaro. These compounded versions, however, have not been evaluated for safety or efficacy. Moreover, with 136 adverse events reported, there has been a rise in concerns about the health and safety of patients using these medications.
Increase in Lawsuits Against Eli Lilly
The resolution of tirzepatide shortages in October 2024 increased Mounjaro’s availability, leading to a surge in lawsuits against its manufacturer, Eli Lilly. Over 1,090 cases have been filed, with claims of severe side effects such as gastroparesis and gastrointestinal injuries. As awareness of these risks grows, more individuals are expected to file lawsuits.
Carcinogenic Concerns With GLP-1 Drugs
A November 2024 French study linked GLP-1 drugs like Mounjaro to a 58% higher risk of thyroid cancer. As a result, researchers are calling for additional studies to confirm these findings, which have raised serious concerns about the drug’s safety.
Bellwether Trials and Future Implications
The courts will begin bellwether trials for the Mounjaro lawsuits in 2025. These trials will play a vast role in shaping settlements for thousands of pending cases. Recently, court orders initiated the discovery process, focusing on Eli Lilly’s internal communications to uncover crucial evidence.
Who is Filing the Mounjaro Lawsuits?
Individuals who have suffered severe health complications, including gastrointestinal issues, thyroid cancer, and vision loss, are filing Mounjaro lawsuits. A recent lawsuit ( November 21, 2024) was filed by a 46-year-old woman from Alabama in the United States District Court, alleging severe health complications linked to her use of Mounjaro.
According to the complaint, she used the drug from August 2022 to April 2023 and experienced serious gastrointestinal issues, including delayed gastric emptying. The lawsuit further highlights that her doctor was unaware of major risks associated with the medication, such as gastroparesis, a condition that impairs the stomach’s ability to empty properly.
These risks were not widely disclosed, leaving you in the dark. Take a stand and hold the responsible parties accountable. Contact our skilled Mounjaro attorneys at Uptown Injury Law, PLLC, today for a FREE, no-obligation case evaluation.
What Does the Mounjaro Lawsuits Claim?
Mounjaro lawsuits claim that Eli Lilly, the manufacturer, failed to warn users and doctors about serious gastrointestinal issues, including gastroparesis and delayed gastric emptying. Plaintiffs argue that the pharmaceutical company had a legal duty to disclose these risks but did not, leading to severe health complications for users.
Furthermore, the claims allege that Eli Lilly marketed Mounjaro as a safe weight loss drug despite evidence of the severe side effects. According to plaintiffs, misleading labeling and advertising influenced their decision to use Mounjaro, resulting in harm that could have been avoided with proper warnings.
What Are the Requirements for Joining Mounjaro Lawsuit?
Joining a Mounjaro lawsuit requires meeting specific eligibility criteria to ensure you have a strong case. This may include the following:
- Provide prescription records or medical reports showing your use of Mounjaro or other weight-loss drugs.
- Evidence of adverse health effects linked to Mounjaro, like gastroparesis or severe gastrointestinal issues.
Since not all side effects qualify for legal action, it’s crucial to work with an experienced Mounjaro attorney to assess your claim properly. Schedule a risk-free consultation with Uptown Injury Law, PLLC, today to protect your rights and determine your eligibility to join a lawsuit.
What Evidence You May Need to Prove Your Mounjaro Claim?
To prove your Mounjaro claim, you must provide clear evidence linking your health issues to the drug. Critical evidence includes:
- Medical Records
- Prescriptions
- Emergency Room Visits
- Doctor’s Notes
By collecting this evidence, you strengthen your claim and demonstrate the impact of the drug on your health. Moreover, to maximize your chances of a successful claim, contact a skilled attorney at Uptown Injury Law, PLLC. We will organize and present all relevant evidence necessary to secure the full settlement you deserve.
What Are the Steps to File Your Mounjaro Lawsuit?
Filing a Mounjaro lawsuit involves the following steps:
- Consult a Mounjaro attorney for a free case review to determine your eligibility.
- Collect medical records, testimonies, and proof of damages.
- File your claim, ensuring your case meets state-specific filing deadlines.
- Pursue a fair settlement or proceed to trial if negotiations are unsuccessful.
Being proactive is crucial to meeting all legal requirements and filing a solid case. A skilled attorney ensures they handle each step, preparing your claim effectively and increasing your chances of obtaining fair compensation.
What Is Mounjaro (Tirzepatide)?
Mounjaro, or tirzepatide, is a prescription drug manufactured by pharmaceutical company Eli Lilly and approved by the FDA in May 2022 for type 2 diabetes. It functions by regulating blood sugar levels through subcutaneous injections.
The drug activates GLP-1 and GIP receptors, which are critical for controlling blood glucose after meals. This dual action makes Mounjaro unique compared to similar medications.
In late 2022, the FDA granted Mounjaro Fast Track designation for obesity treatment and chronic weight management due to its growing popularity. However, while effective for diabetes and weight loss, the drug has caused severe health risks, including delayed gastric emptying and gastrointestinal complications.
These risks have led to lawsuits against Eli Lilly, highlighting concerns about the drug’s safety despite its benefits.
Off-Label Use of Mounjaro for Weight Loss
Mounjaro is not officially designated as a weight loss drug and is only approved by the FDA for type 2 diabetes. However, many individuals and healthcare providers use it off-label for weight management.
Eli Lilly, Mounjaro’s manufacturer, has highlighted its weight loss potential, claiming users have experienced reductions of up to 25 pounds.
However, the drug’s official website explicitly states that it is “not a weight loss drug.”
As demand for weight management medications continues to rise, Mounjaro is positioning itself as a strong competitor to popular alternatives like Ozempic. However, the risks associated with off-label use, including severe gastrointestinal issues, have led to lawsuits against Eli Lilly, highlighting the need for safety and more clinical research.
What Are the Side Effects of Mounjaro?
Mounjaro can cause side effects that range from mild to severe, such as:
- Gastroparesis or gastroenteritis
- Severe abdominal pain, which could indicate pancreas or gallbladder disease
- Persistent nausea or vomiting
- Upset stomach
- Blurred or decreased vision
- Changes in urine output, a possible sign of kidney issues
- Constipation
- Diarrhea
- Loss of appetite
- Fatigue
- Redness, itching, or inflammation at the injection site
Long-term Usage of Mounjaro is Linked to Stomach Paralysis, Blood Clots, and Vision Loss
Long-term use of Mounjaro has been associated with severe health risks, including stomach paralysis, blood clots, and vision loss. These conditions raise concerns for patients taking the medication for extended periods.
Stomach Paralysis (Gastroparesis)
Semaglutides, including Mounjaro, cause stomach paralysis, or gastroparesis, a disorder where the stomach muscles fail to move food effectively. This disrupts digestion, slowing stomach emptying and causing symptoms like persistent nausea and vomiting.
Patients with type 2 diabetes are already at higher risk for gastroparesis due to potential vagus nerve damage. The higher doses of Mounjaro compared to similar GLP-1 drugs may amplify this risk.
Blood Clots
The GLP-1 class of drugs, including Mounjaro, has been linked to deep vein thrombosis (DVT) and pulmonary embolisms (PEs). These blood clots can disrupt circulation, potentially leading to lung damage, organ failure, or even death.
Vision Loss
Researchers have linked GLP-1 receptor agonists to an increased risk of NAION, which cuts off blood supply to the eye and leads to vision loss or blindness. Although experts need more research to confirm Mounjaro’s link to this risk, its classification suggests a potential connection.
Who Is the Manufacturer of Mounjaro Tirzepatide?
Eli Lilly and Company, a global pharmaceutical company, is the manufacturer of Mounjaro (tirzepatide). The drug received FDA approval on May 13, 2022, for managing type 2 diabetes in adults.
Tirzepatide, also sold under the brand names Mounjaro and Zepbound, has come under scrutiny following reports of adverse health events. Allegations against Eli Lilly claim that the company failed to warn patients about serious risks, including gastroparesis, leading to lawsuits and raising concerns about the drug’s safety.
Statute of Limitation to File a Mounjaro Lawsuit
In New York City, the statute of limitations to file a Mounjaro lawsuit is three years. This period generally begins on the date the injury occurred or when you discovered the harm caused by the drug.
However, you should promptly take legal action, as these legal deadlines vary by state and depend on the specifics of your case.
If you miss the deadline, you lose the right to seek compensation. Therefore, you should consult an experienced attorney who ensures you meet the legal filing requirements while building a solid foundation for your case.
Mounjaro Class Action Lawsuits
Currently, there is no active Mounjaro class action lawsuit. Instead, claims against Eli Lilly have been consolidated into multidistrict litigation (MDL). This legal process groups individual lawsuits with similar allegations, such as failure to warn about severe side effects like gastroparesis and gastrointestinal issues.
Additionally, a Mounjaro MDL allows each plaintiff to maintain their own case while streamlining pretrial proceedings. To explore your legal options, consult an experienced Mounjaro lawyer at Uptown Injury Law, PLLC. We can guide you through the MDL process and help you seek the compensation you’re entitled to.
Damages Plaintiffs May Seek In a Mounjaro Lawsuit
If Mounjaro has harmed you, you can pursue compensation for the following damages:
- Medical expenses
- Pain and suffering
- Lost wages
- Attorney’s fees
- Punitive damages
The damages you seek depend on the specifics of your case. At Uptown Injury Law, PLLC, our lawyers can assess your claim, explain your legal options, and calculate a potential settlement you deserve.
How Much Is the Settlement Amount in a Mounjaro Lawsuit?
Mounjaro settlement for conditions like gastroparesis may range from $400,000 to $700,000. The settlement amounts can vary depending on factors such as the severity of your condition and the duration of your treatment.
Therefore, only an experienced attorney can provide an accurate estimate by carefully evaluating the unique details of your case. Call Uptown Injury Law, PLLC, toll-free at 917-540-8728 to ensure you fully understand your legal options and potential compensation.
Don’t Wait —File Your Claim With New York’s Best Mounjaro Lawyers!
Time is short when filing a Mounjaro lawsuit, as legal deadlines can limit your ability to seek compensation. If you’ve suffered serious side effects from Mounjaro, pursue legal action immediately to protect your rights.
At Uptown Injury Law, PLLC, our award-winning attorneys specialize in holding pharmaceutical companies accountable for their negligence. You can pursue justice without financial risk with our no-win, no-fee policy.
Call 917-540-8728 today or schedule a FREE consultation online. Our New York’s leading Mounjaro attorneys fight for the compensation you deserve.
FAQS
What Are the Symptoms of Stomach Paralysis With Mounjaro?
The symptoms of stomach paralysis with Mounjaro include nausea, vomiting, and severe abdominal pain. Patients may also experience bloating and difficulty eating. If you’re facing these symptoms, seek medical help immediately and learn about your legal rights to seek compensation.
What Is the Difference Between Mounjaro and Ozempic?
Ozempic and Mounjaro are both FDA-approved medications for managing Type 2 diabetes, but they differ in their active ingredients and mechanisms.
Ozempic contains semaglutide, while Mounjaro uses tirzepatide, which also targets glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) for enhanced effects. While both help control blood sugar levels, Mounjaro may provide more significant weight loss benefits.
How Long Does it Take to Resolve a Mounjaro Lawsuit?
Resolving a Mounjaro lawsuit takes several months to years, depending on the complexity of the case and the legal process involved. Factors such as evidence gathering, status conferences, and settlement negotiations can significantly influence the Mounjaro MDL timeline.
Who Can File a Mounjaro Stomach Paralysis Claim?
Individuals who have experienced severe digestive issues, such as stomach paralysis, after taking Mounjaro may be eligible to file a claim. Eligibility generally requires medical evidence establishing a link between the condition and the use of Mounjaro.
How Much Does It Cost to Hire a Mounjaro Lawsuit Attorney?
Hiring a Mounjaro lawsuit attorney involves no upfront costs, as most law firms operate on a contingency fee basis. In this arrangement, fees are only deducted from Mounjaro settlements if your case is successful. Therefore, this structure ensures you can confidently pursue justice for serious health issues without facing financial risk.
Does Mounjaro Cause Gastric Paralysis?
Mounjaro has been linked to cases of gastric paralysis, as reported in adverse event reports. Although rare, this serious health issue has raised significant concerns about the medication’s effects on the digestive system. Therefore, if you’ve experienced these symptoms, it is crucial to consult a Mounjaro lawyer and explore your legal options
How to Choose the Right Mounjaro Lawyer?
Choose a lawyer with strong expertise and a track record in pharmaceutical litigation. A reputable lawyer should have positive client testimonials and a proven ability to obtain favorable outcomes through strong negotiation skills.
Select an attorney who demonstrates compassion and empathy, providing personalized support during the legal process. Furthermore, your lawyer should keep you informed throughout the process and prioritize your best interests and maximum compensation.
